Abbass Darwich is a biomarker strategy leader in immuno-oncology with extensive experience in pre-clinical and clinical research. They have contributed to the discovery and characterization of innovative therapies, including a first-in-class immune checkpoint antibody. Abbass has served as a postdoctoral scientist at Humanitas Research Hospital and held various roles, including senior scientist at Honing Biosciences, where they developed next-generation therapies. Currently pursuing a Master's degree in Biotechnology and Therapeutic Research at Université de Nantes, Abbass is committed to mentorship and collaboration in innovative research environments.
This person is not in the org chart
This person is not in any teams
This person is not in any offices